Benzodiazepine bromodomain inhibitor

Details for Australian Patent Application No. 2010314395 (hide)

Owner GlaxoSmithKline LLC

Inventors Gosmini, Romain Luc Marie; Mirguet, Olivier

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010314395

PCT Pub. Number WO2011/054553

Priority 1010509.6 22.06.10 GB; 0919433.3 05.11.09 GB

Filing date 6 August 2010

Wipo publication date 12 May 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054553 Priority application(s): WO2011/054553

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314413-Lubricant compositions

2010314369-Airflow adaptor for a breath-actuated dry powder inhaler